MeiraGTx Holdings (MGTX) Long-Term Investments (2021 - 2025)
MeiraGTx Holdings (MGTX) reported Long-Term Investments of $6.7 million for Q4 2025, little changed on a YoY basis from $6.7 million in Q4 2024, and little changed quarter-over-quarter from $6.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) Long-Term Investments (2021 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Long-Term Investments for 5 years, with the latest figure at $6.7 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments changed 0.0% year-over-year to $6.7 million; the trailing twelve-month figure through Dec 2025 stood at $6.7 million (changed 0.0% YoY), and the FY2025 full-year result was $6.7 million, changed 0.0% from the prior year.
- Long-Term Investments for Q4 2025 stood at $6.7 million, roughly flat from $6.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $6.8 million in Q4 2023, with the low at $1.5 million in Q1 2021.
- Historically, Long-Term Investments has averaged $5.6 million across 5 years, with a median of $6.7 million in 2021.
- The largest YoY upside for Long-Term Investments was 343.73% in 2022 against a maximum downside of 77.49% in 2022.
- MeiraGTx Holdings' Long-Term Investments stood at $6.7 million in 2021, then decreased by 4.96% to $6.3 million in 2022, then gained by 6.96% to $6.8 million in 2023, then decreased by 0.25% to $6.7 million in 2024, then changed by 0.0% to $6.7 million in 2025.
- The last three Long-Term Investments figures came in at $6.7 million (Q4 2025), $6.7 million (Q3 2025), and $6.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 6.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.75 Mn |
| Jun 30, 2025 | 6.75 Mn |
| Mar 31, 2025 | 6.75 Mn |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | 6.77 Mn |
| Jun 30, 2024 | 6.77 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 6.33 Mn |
| Mar 31, 2023 | 6.33 Mn |
| Dec 31, 2022 | 6.33 Mn |
| Sep 30, 2022 | 6.66 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 6.66 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 6.67 Mn |
| Mar 31, 2021 | 1.50 Mn |